These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20562101)

  • 1. The CXC chemokine-degrading protease SpyCep of Streptococcus pyogenes promotes its uptake into endothelial cells.
    Kaur SJ; Nerlich A; Bergmann S; Rohde M; Fulde M; Zähner D; Hanski E; Zinkernagel A; Nizet V; Chhatwal GS; Talay SR
    J Biol Chem; 2010 Sep; 285(36):27798-805. PubMed ID: 20562101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killing.
    Zinkernagel AS; Timmer AM; Pence MA; Locke JB; Buchanan JT; Turner CE; Mishalian I; Sriskandan S; Hanski E; Nizet V
    Cell Host Microbe; 2008 Aug; 4(2):170-8. PubMed ID: 18692776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract.
    Kurupati P; Turner CE; Tziona I; Lawrenson RA; Alam FM; Nohadani M; Stamp GW; Zinkernagel AS; Nizet V; Edwards RJ; Sriskandan S
    Mol Microbiol; 2010 Jun; 76(6):1387-97. PubMed ID: 20158613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection.
    Turner CE; Kurupati P; Jones MD; Edwards RJ; Sriskandan S
    J Infect Dis; 2009 Aug; 200(4):555-63. PubMed ID: 19591574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response.
    Sumby P; Zhang S; Whitney AR; Falugi F; Grandi G; Graviss EA; Deleo FR; Musser JM
    Infect Immun; 2008 Mar; 76(3):978-85. PubMed ID: 18174342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of SpyCEP, a candidate antigen for a vaccine against Streptococcus pyogenes.
    Abate F; Malito E; Falugi F; Margarit Y Ros I; Bottomley MJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Oct; 69(Pt 10):1103-6. PubMed ID: 24100558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pyogenes SpyCEP: a chemokine-inactivating protease with unique structural and biochemical features.
    Zingaretti C; Falugi F; Nardi-Dei V; Pietrocola G; Mariani M; Liberatori S; Gallotta M; Tontini M; Tani C; Speziale P; Grandi G; Margarit I
    FASEB J; 2010 Aug; 24(8):2839-48. PubMed ID: 20339024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP.
    Goldblatt J; Lawrenson RA; Muir L; Dattani S; Hoffland A; Tsuchiya T; Kanegasaki S; Sriskandan S; Pease JE
    J Immunol; 2019 Jun; 202(11):3246-3255. PubMed ID: 31010851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pyogenes SpyCEP influences host-pathogen interactions during infection in a murine air pouch model.
    Chiappini N; Seubert A; Telford JL; Grandi G; Serruto D; Margarit I; Janulczyk R
    PLoS One; 2012; 7(7):e40411. PubMed ID: 22848376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity studies of Streptococcus pyogenes enzyme SpyCEP reveal high affinity for CXCL8 in the SpyCEP C-terminal.
    Pearson M; Haslam C; Fosberry A; Jones EJ; Reglinski M; Reeves L; Edwards RJ; Lawrenson RA; Brown JC; Mossakowska D; Pease JE; Sriskandan S
    Sci Rep; 2023 Nov; 13(1):19052. PubMed ID: 37923786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group A
    Soderholm AT; Barnett TC; Korn O; Rivera-Hernandez T; Seymour LM; Schulz BL; Nizet V; Wells CA; Sweet MJ; Walker MJ
    Front Cell Infect Microbiol; 2018; 8():160. PubMed ID: 29868516
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemokine degradation by the Group A streptococcal serine proteinase ScpC can be reconstituted in vitro and requires two separate domains.
    Fritzer A; Noiges B; Schweiger D; Rek A; Kungl AJ; von Gabain A; Nagy E; Meinke AL
    Biochem J; 2009 Aug; 422(3):533-42. PubMed ID: 19552626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi.
    Turner CE; Kurupati P; Wiles S; Edwards RJ; Sriskandan S
    Vaccine; 2009 Aug; 27(36):4923-9. PubMed ID: 19563892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes.
    Edwards RJ; Taylor GW; Ferguson M; Murray S; Rendell N; Wrigley A; Bai Z; Boyle J; Finney SJ; Jones A; Russell HH; Turner C; Cohen J; Faulkner L; Sriskandan S
    J Infect Dis; 2005 Sep; 192(5):783-90. PubMed ID: 16088827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of ScpC, a virulence protease from
    Jobichen C; Tan YC; Prabhakar MT; Nayak D; Biswas D; Pannu NS; Hanski E; Sivaraman J
    Biochem J; 2018 Sep; 475(17):2847-2860. PubMed ID: 30049896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, dynamics and immunogenicity of a catalytically inactive C
    McKenna S; Malito E; Rouse SL; Abate F; Bensi G; Chiarot E; Micoli F; Mancini F; Gomes Moriel D; Grandi G; Mossakowska D; Pearson M; Xu Y; Pease J; Sriskandan S; Margarit I; Bottomley MJ; Matthews S
    Comput Struct Biotechnol J; 2020; 18():650-660. PubMed ID: 32257048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-8 protease SpyCEP is detrimental for Group A Streptococcus host-cells interaction and biofilm formation.
    Andreoni F; Ogawa T; Ogawa M; Madon J; Uchiyama S; Schuepbach RA; Zinkernagel AS
    Front Microbiol; 2014; 5():339. PubMed ID: 25071751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model.
    Sjölinder H; Lövkvist L; Plant L; Eriksson J; Aro H; Jones A; Jonsson AB
    Infect Immun; 2008 Sep; 76(9):3959-66. PubMed ID: 18573900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opacity factor activity and epithelial cell binding by the serum opacity factor protein of Streptococcus pyogenes are functionally discrete.
    Gillen CM; Courtney HS; Schulze K; Rohde M; Wilson MR; Timmer AM; Guzman CA; Nizet V; Chhatwal GS; Walker MJ
    J Biol Chem; 2008 Mar; 283(10):6359-66. PubMed ID: 18180300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.